Vit D and Heart   Vit D Council     most of these are available on-line
    * Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden. Arch Gerontol Geriatr. 2009 Sep–Oct;49(2):250–4.
    * Vitamin D Receptor (VDR) Polymorphisms in the Cardiac Variant of Gaucher Disease. Pediatr Cardiol. 2009 Sep 26.
    * Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens. 2009 Sep 16.
    * Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf. 2009 Sep 15.
    * Vitamin D supplements vs plasma level. Arch Intern Med. 2009 Sep 14;169(16):1536; author reply 1536–7.
    * Vitamin D: bone and beyond, rationale and recommendations for supplementation. Am J Med. 2009 Sep;122(9):793–802. Review.
    * Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care. 2009 Aug 25.
    * Peripartum cardiomyopathy in an obese pregnant woman. Ugeskr Laeger. 2009 Aug 24;171(35):2487–9.
    * Calcium and Vitamin D Status in Heart Failure Patients in Isfahan, Iran. Biol Trace Elem Res. 2009 Aug 19.
    * Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004. Pediatrics. 2009 Aug 3.
    * Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population. Pediatrics. 2009 Aug 3.
    * 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol. 2009 Aug;20(8):1805–12.
    * Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults. Am J Ther. 2009 Jul–Aug;16(4):326–32.
    * The role of vitamin D in the development of cardiac failure. Orv Hetil. 2009 Jul 26;150(30):1397–402.
    * Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009 Jul;338(1):40–4.
    * Vitamin d and cardiovascular disease. Curr Vasc Pharmacol. 2009 Jul;7(3):414–22.
    * Differences in vitamin D levels likely explain ethnic differences in incidence of congestive heart failure. Arch Intern Med. 2009 Jun 8;169(11):1075.
    * Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis. 2009 Jun 6.
    * Circulating calcitriol concentrations and total mortality. Clin Chem. 2009 Jun;55(6):1163–70.
    * Vitamin D and cardiovascular disease. Pharmacotherapy. 2009 Jun;29(6):691–708.
    * Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med Hypotheses. 2009 Jun;72(6):647–51.
    * Vitamin D deficiency and myocardial dysfunction. J Am Coll Cardiol. 2009 May 26;53(21):2011; author reply 2012–3.
    * Effect of a Combined Therapeutic Approach of Intensive Lipid Management, Omega-3 Fatty Acid Supplementation, and Increased Serum 25 (OH) Vitamin D on Coronary Calcium Scores in Asymptomatic Adults. Am J Ther. 2009 May 19.
    * Vitamin D Deficiency and Its Correlations With Increased Cardiovascular Incidences. Am J Ther. 2009 May 15.
    * Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab. 2009 May;94(5):1483–90.
    * Methodology and baseline characteristics for the Sarcopenia and Hip Fracture study: a 5-year prospective study. J Gerontol A Biol Sci Med Sci. 2009 May;64(5):568–74.
    * Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2009 May;64(5):559–67.
    * Consequences of a plant-based diet with low dairy consumption on intake of bone-relevant nutrients. J Womens Health (Larchmt). 2009 May;18(5):691–8.
    * Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias? Med Hypotheses. 2009 May;72(5):581–3.
    * Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension. Open Respir Med J. 2009 Apr 14;3:53–60.
    * Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res. 2009 Apr 10;104(7):851–9.
    * Circulating Calcitriol Concentrations and Total Mortality. Clin Chem. 2009 Apr 9.
    * Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol. 2009 Mar 3.
    * Reduced relative lymphocyte count in african-americans with decompensated heart failure. Am J Med Sci. 2009 Mar;337(3):156—60.
    * Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish. Calcif Tissue Int. 2009 Mar;84(3):195–202.
    * Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res. 2009 Feb 15;81(3):500–8. Review.
    * Some new food for thought: the role of vitamin D in the mental health of older adults. Curr Psychiatry Rep. 2009 Feb;11(1):12–9.
    * 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009 Feb;24(2):611–8.
    * Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61. Review.
    * Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets. 2009 Jan;13(1):29–38.
    * Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Presse Med. 2009 Jan;38(1):43–54. Review in French.
    * Vitamin D: current status and perspectives. Clin Chem Lab Med. 2008 Dec 22.
    * Effect of a Combined Therapeutic Approach of Intensive Lipid Management, Omega-3 Fatty Acid Supplementation, and Increased Serum 25 (OH) Vitamin D on Coronary Calcium Scores in Asymptomatic Adults. Am J Ther. 2008 Dec 15.
    * Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr. 2008 Dec;88(6):1469–77.
    * Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension. 2008 Dec;52(6):1106–12.
    * A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. Eur J Endocrinol. 2008 Dec;159 Suppl 1:S101–5.
    * The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361–8. Review.
    * Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008 Dec;15(6):489–94. Review.
    * Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris). 2008 Dec;69(6):501–10. In French.
    * Adequate level of vitamin D is essential for maintaining good health. Postepy Hig Med Dosw (Online). 2008 Oct 9;62:502–10. In Polish.
    * Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726–76. Review.
    * Vitamin D and Sunlight: Strategies for Cancer Prevention and Other Health Benefits. Clin J Am Soc Nephrol. 2008 Sep;3(5):1548–54.
    * Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: Interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol. 2008 Aug 20;590(1–3):290–6.
    * 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11;168(15):1629–37.
    * Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008 Aug;19(8):1509–19.
    * Vitamin D and anti-aging medicine. Clin Calcium. 2008 Jul;18(7):980–5. Review in Japanese.
    * The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):408–15. Review.
    * Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144–51.
    * Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
    * Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38. Review.
    * Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis). Nefrologia. 2008;28 Suppl 3:67–78. In Spanish.
    * Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730–7. Review.
    * 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007 Jul;50(1):69–77.
    * Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Ann Clin Lab Sci. 2007 Summer;37(3):222–32.
    * Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States. Arch Intern Med. 2007 Jun 11;167:1159–1165.
    * 25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men. Arch Intern Med. 2008 Jun 9;168(11):1174–1180.
    * Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
    * Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol. 2008;23(9):609–14.
    * Hypocalcemia as a Cause of Reversible Cardiomyopathy with Ventricular Tachycardia. Ann Intern Med. 3 April 2007 | Volume 146 Issue 7 | Pages 541–542.
    * Effects of atorvastatin on vitamin d levels in patients with acute ischemic heart disease. Am J Cardiol. 2007 Apr 1;99(7):903–5.
    * Vitamin D supplementation and cardiovascular disease risk. Circulation. 2007 Feb 20;115(7):827–8. Editorial.
    * Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007 Feb 20;115(7):846–54.
    * Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb;18(1):41–6. Review.
    * Nutritional vitamin D deficiency presenting as hemichorea. J Child Neurol. 2007 Jan;22(1):74–6.
    * Effects of the Phytoestrogen Genistein on Some Predictors of Cardiovascular Risk in Osteopenic, Postmenopausal Women: A Two-Year Randomized, Double-Blind, Placebo-Controlled Study. J Clin Endocrinol Metab. 2007 Vol. 92, No. 8 3068–3075.
    * Relationships between Myocardial Injury, All-cause Mortality, Vitamin D, PTH, and Biochemical Bone Turnover Markers in Older Patients with Hip Fractures. Annals of Clinical and Laboratory Science 37:222–232 (2007).
    * Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res. 2006 Dec;148(6):301–8.
    * Hypothesis: Correction of low vitamin D status among Arab women will prevent heart failure and improve cardiac function in established heart failure. Eur J Heart Fail. 2006 Nov;8(7):694–6.
    * Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf). 2006 Nov;65(5):593–597.
    * Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79. Review.
    * Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Sep;92(1):39–48. Review.
    * Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):640–6.
    * Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing "betel nut" (Areca catechu) and vitamin D status. J Clin Endocrinol Metab. 2006 Jul;91(7):2612–7.
    * Osteoporotic fractures and vitamin D deficiency. Aust Fam Physician. 2006 Jul;35(7):519–20, 522.
    * Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther. 2006 Jul;318(1):90–8.
    * Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis. 2006 May;186(1):20–8.
    * Vitamin D and African Americans. J Nutr. 2006 Apr;136(4):1126–9.
    * Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev. 2006 Mar;11(1):25–33.
    * Cardiovascular disease in chronic kidney failure: the role of VDR activators. Curr Opin Investig Drugs. 2006 Mar;7(3):206–13. Review.
    * Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43. Review.
    * Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci. 2006 Jan;331(1):30–4.
    * Kidneys, hearts, hormones and immunomodulators: integrated understandings. Blood Purif. 2006;24(1):46–50. Review.
    * Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem. 2005 Nov 25;280(47):39394–402.
    * Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005 Nov;68(5):1973–81. Review.
    * Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005 Oct;98(10):1024–7. Review.
    * The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):307–14. Review.
    * Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75. Review.
    * Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
    * Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56. Review.
    * Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar;79(3):362–71. Review.
    * Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003 Jan 1;41(1):105–12.
    * Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol. 2002 Jul;16(7):1524–37.
    * Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall study. Int J Epidemiol. 2001 Oct;30(5):1109–16.
    * Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol. 2001;17(6):567–71.
    * Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol. 1998 May;31(6):1226–33.
    * Absence of a seasonal variation in myocardial infarction onset in a region without temperature extremes. Cardiology. 1998 May;89(4):277–82.
    * Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997 Sep;103(3):197–207.
    * Seasonal pattern of acute myocardial infarction in the National Registry of Myocardial Infarction. J Am Coll Cardiol. 1996 Dec;28(7):1684–8.
    * Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995 Sep;8(9):894–901.
    * Serum 25-hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforce. Aust N Z J Med. 1995 Jun;25(3):218–23.
    * Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol. 1992 Sep;2(5):697–703.
    * Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990 Sep;19(3):559–63.
    * Changes in plasma vitamin levels in the first 48 hours after onset of acute myocardial infarction. Am J Cardiol. 1989 Nov 1;64(16):971–4.